Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia-Reference-Cited by-同舟云学术

Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia

Published:2010-04-22 Issue:5 Volume:52 Page:744-748
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:

Author:

Yagi Mariko,Nakamura Tsutomu,Okizuka Yo,Oyazato Yoshinobu,Kawasaki Yoko,Tsuneishi Shuichi,Sakaeda Toshiyuki,Matsuo Masafumi,Okumura Katsuhiko,Okamura Noboru

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-200X.2010.03157.x/fullpdf

Reference14 articles.

1. Practitioner review: Use of antiepileptic drugs in children;Guerrini;J. Child Psychol. Psychiatry,2006

2. Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience;Perucca;CNS Drugs,2002

3. Valproate-induced hyperammonemic encephalopathy;Segura-Bruna;Acta Neurol. Scand.,2006

4. The measurement of ammonia blood levels in patients taking valproic acid: Looking for problems where they do not exist?;Chicharro;Epilepsy Behav.,2007

5. Valproate-induced hyperammonaemic encephalopathy: Review of 14 cases in the psychiatric setting;Dealberto;Int. Clin. Psychopharmacol.,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of glutamine synthetase polymorphisms rs2296521, rs10911021 and rs12136955 with plasma ammonia concentration in valproic acid-treated Egyptian epilepsy patients;Neurologia i Neurochirurgia Polska;2024-08-21

2. Therapeutic and Toxic Effects of Valproic Acid Metabolites;Metabolites;2023-01-16

3. HYPERAMMONAEMIA AND COGNITIVE IMPAIRMENT IN EPILEPSY PATIENTS TREATED WITH VALPROIC ACID – PRELIMINARY STUDY;Wiadomości Lekarskie;2022

4. A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency;Case Reports in Neurological Medicine;2021-12-31

5. Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment;Epilepsy & Behavior;2021-07